These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Myelosuppression and "conventional" chemotherapy: what price, what benefit? Canellos GP; Demetri GD J Clin Oncol; 1993 Jan; 11(1):1-2. PubMed ID: 8418220 [No Abstract] [Full Text] [Related]
4. [Clinical use of hematopoietic growth factors]. Gianni AM; Bregni M; Siena S; Tarella C; DiNicola M; Bonadonna G Haematologica; 1991 Jun; 76 Suppl 3():3-10. PubMed ID: 1752526 [No Abstract] [Full Text] [Related]
5. The use of hematopoietic growth factors to support cytotoxic chemotherapy for patients with breast cancer. Demetri GD Hematol Oncol Clin North Am; 1994 Feb; 8(1):233-49. PubMed ID: 8150782 [TBL] [Abstract][Full Text] [Related]
6. The use of hematological growth factors to enable dose intensification in chemotherapy for soft tissue sarcomas. Liem GS; Verweij J Stem Cells; 1994 Jul; 12(4):402-8. PubMed ID: 7951007 [TBL] [Abstract][Full Text] [Related]
7. The role of hematopoietic growth factors in transfusion medicine. Whitsett CF Hematol Oncol Clin North Am; 1995 Feb; 9(1):23-68. PubMed ID: 7737944 [TBL] [Abstract][Full Text] [Related]
8. Critical review of the role of hemopoietic growth factors in dose intensification and outcome in the treatment of non-Hodgkin's lymphoma. Canellos GP Ann Oncol; 1994; 5 Suppl 2():121-2. PubMed ID: 8204512 [No Abstract] [Full Text] [Related]
9. Pathology induced by hematopoietic growth factors. Introduction. Ryffel B Int Rev Exp Pathol; 1993; 34 Pt A():113-8. PubMed ID: 8454410 [No Abstract] [Full Text] [Related]
11. Hematopoietic growth factors. A promising future for use in bone marrow dysfunction. Mazza JJ; Reding DJ; Plank GS Postgrad Med; 1992 Jun; 91(8):299-302, 305, 309 passim. PubMed ID: 1603758 [TBL] [Abstract][Full Text] [Related]
12. [Clinical use of hematopoietic growth factors in treatment of bone marrow failure]. Robak T; Krykowski E Pol Arch Med Wewn; 1994 Jul; 92(1):1-8. PubMed ID: 7971472 [No Abstract] [Full Text] [Related]
13. Biotherapy in hematology: the next decade. Quesenberry PJ Rev Invest Clin; 1994 Apr; Suppl():8-15. PubMed ID: 7886315 [No Abstract] [Full Text] [Related]
14. Hematopoietic growth factors as supportive therapy for cancer- and chemotherapy-induced conditions. Symann M Curr Opin Oncol; 1991 Aug; 3(4):648-55. PubMed ID: 1932223 [TBL] [Abstract][Full Text] [Related]
16. The present and future of hematopoietic cytokines in clinical practice. George MJ Stem Cells; 1994; 12 Suppl 1():249-55. PubMed ID: 7696964 [TBL] [Abstract][Full Text] [Related]
17. [Use of hematopoietic growth factors in oncology]. Delmer A; Zittoun R Bull Cancer; 1991; 78(2):115-31. PubMed ID: 2036483 [TBL] [Abstract][Full Text] [Related]
18. The use of peripheral stem cell support of high-dose chemotherapy. Kessinger A; Armitage JO Important Adv Oncol; 1993; ():167-75. PubMed ID: 8099339 [TBL] [Abstract][Full Text] [Related]